Generational Capital Markets Member FINRA/SIPC

Completed Transactions

Completed Transactions > Healthcare & Life Sciences > Navix Holdings Corp. Acquired By A Private Investment Firm

Navix Holdings Corp. Acquired By A Private Investment Firm

Navix Diagnostix


Apr 2021



Completed By

We are pleased to announce the sale of Navix Holdings Corp. and its subsidiary, Navix Diagnostix, Inc. (a portfolio company of Prospect Partners), to a Private Investment Firm. The acquisition closed April 30, 2021.

Prospect Partners is a leading lower-middle-market private equity firm based in Chicago. The firm focuses exclusively on management-led leveraged recapitalizations and acquisitions of small companies with niche strategies.

Prospect Partners is a highly experienced, active, and committed investor in smaller lower-middle-market companies with revenues typically under $75 million and EBITDA between $2 - $8 million.

Since 1998, it has invested nationwide in more than 150 unique companies to build 52 platforms in a broad range of niche markets, including manufacturing, value-added distribution, food, consumer, and specialty business and consumer services.

Located in Taunton, Massachusetts, Navix Diagnostix, Inc. (Navix) is the market leader in providing outsourced cardiovascular services, specializing in the management of noninvasive vascular labs.

The company is nationally accredited by the Intersocietal Accreditation Commission for vascular, echocardiography and nuclear medicine. Navix partners with hospitals, access centers and physician practices to deliver high-quality, cost-effective testing services that achieve the best outcomes for patients.

Generational Capital Markets (GCM) acted as the exclusive investment banking advisor to Prospect Partners, working closely with the shareholders and Navix management team throughout the sale process to provide advisory expertise and manage the marketing, negotiation and due diligence phases of the transaction.

GCM’s Senior Managing Director of Mergers & Acquisitions, Phil Pizzurro, with support from Managing Director of Mergers & Acquisitions, Don Ho, successfully closed the deal.

“We are delighted to have represented Prospect Partners in its divestiture of Navix,” said Phil Pizzurro.

Pizzurro added, “Navix has a unique value proposition in the outsourced cardiovascular space, and we feel confident its new partner will be able to build upon the company’s success and continue to deliver world-class healthcare services to new and existing customers nationwide.”

If you would like to explore other transactions our associates have supported in this industry, visit our dedicated Healthcare & Life Sciences M&A Deals page.

We have a commitment to our clients’ assurance that extends beyond our service and we are proud to hold FINRA & SIPC memberships.